Tampere University Hospital is a teaching hospital of Tampere University along Teiskontie at the Kauppi district in Tampere, Finland.

There are 1,000 beds in Department of Urology-Tampere University Hospital-.

During the past decade, Department of Urology-Tampere University Hospital- conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Urology-Tampere University Hospital-" #1 sponsor was "Steba Biotech S.A." with 2 trials, followed by "BioCis Pharma Ltd" with 1 trials sponsored, "Camurus AB" with 1 trials sponsored, "Tampere University Hospital" with 1 trials sponsored and "Turku University Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Urology-Tampere University Hospital-" #1 collaborator was "Fimlab laboratories" with 1 trials as a collaborator, "FinnMedi Oy" with 1 trials as a collaborator, "Finnish Cultural Foundation" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "International Drug Development Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Department of Urology-Tampere University Hospital-" are "Prostate Cancer" (3 trials), "Cancer of the Prostate" (1 trials), "Non-muscle Invasive Bladder Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Department of Urology-Tampere University Hospital-" in a lesser frequency.

Most popular intervention types in "Department of Urology-Tampere University Hospital-" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin" (1 trials), "Placebo" (1 trials), "TOOKAD® Soluble" (1 trials), "cis-UCA solution" (1 trials) and "leuprolide acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Urology-Tampere University Hospital-" are 5 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Department of Urology-Tampere University Hospital-". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Department of Urology-Tampere University Hospital-, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Urology-Tampere University Hospital-, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".